Photo

Photo detail

Stories this photo appears in:

Pyott Gives $6.5M to Alma Mater

David Pyott, retired chief executive of Allergan, has donated 4.3 million pounds, or $6.5 million, to the London Business School.

Tease photo

Pyott Gets $534M on Allergan Sale

David Pyott, the former chief executive of Irvine-based Allergan Inc., converted stock to a total of $534 million in cash following Allergan’s $72.5 billion acquisition by Actavis Plc, according to a Securities and Exchange Commission filing.

Tease photo

Pyott Gets $534M on Allergan Sale

David Pyott, the former chief executive of Irvine-based Allergan Inc., converted stock to a total of $534 million in cash following Allergan’s $72.5 billion acquisition by Actavis Plc, according to a Securities and Exchange Commission filing.

Tease photo

Pyott to Retain Chair of Allergan Foundation

David Pyott will remain chair of the Allergan Foundation, according to Actavis PLC, the Ireland-based drug maker that recently wrapped up its $72.5 billion buy of Irvine-based Allergan Inc.

Tease photo

Pyott in Line for $100M Payout

Allergan Inc. Chief Executive David Pyott is in line for a severance payment of $100 million as a result of Actavis PLC’s pending buy of the Irvine-based drug maker, according to a federal filing.

Tease photo

Allergan Acquired by Actavis for $66B

Irvine-based Allergan Inc. has agreed to be acquired for $66 billion by Actavis PLC.

Tease photo

Pyott Leaves Edwards Board

Allergan Inc. Chief Executive David Pyott has resigned as a director of Edwards Lifesciences Corp.

Tease photo

Pyott Leaves Edwards Board

Allergan Inc. Chief Executive David Pyott has resigned as a director of Edwards Lifesciences Corp.

Tease photo

Allergan Sets Special Shareholder Meeting

Irvine-based Allergan Inc. will host a special shareholders’ meeting on Dec. 18, according to a court filing today.

Tease photo

Allergan Contends Insider Trading in Suit against Valeant, Ackman

Irvine-based Allergan Inc. filed a federal lawsuit today that contends hostile suitor Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman engaged in insider trading.

Tease photo

Job Cuts at Allergan HQ Could be Offset

Allergan Inc. said it will close three of its facilities around the U.S. and lay off about 1,500 employees over the next several months as part of a restructuring plan.

Tease photo

Job Cuts at Allergan HQ Could be Offset

Allergan Inc. said it will close three of its facilities around the U.S. and lay off about 1,500 employees over the next several months as part of a restructuring plan.

Tease photo

Allergan Board Rejects New Valeant Bid

Irvine-based Allergan Inc. said today that its board rejected a revised hostile takeover bid worth about $53 billion from Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP.

Tease photo